Cargando…
Evaluation of Hematological Profile in Oral Submucous Fibrosis
Background: The aim of the study is to assess the hematological profile in oral submucous fibrosis (OSMF) patients. Methods: The study's participants (100) were divided into two groups. Group I consisted of fifty areca nut chewers with complaints of burning sensations, blanching, and stiffness...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900455/ https://www.ncbi.nlm.nih.gov/pubmed/35265435 http://dx.doi.org/10.7759/cureus.21926 |
_version_ | 1784664118178873344 |
---|---|
author | Abidullah, Mohammed Gaddikeri, Kavitha Anjum, Bushra Vairagare, Swapneel Tarani, Kulkarni Seethamsetty, Swetcha |
author_facet | Abidullah, Mohammed Gaddikeri, Kavitha Anjum, Bushra Vairagare, Swapneel Tarani, Kulkarni Seethamsetty, Swetcha |
author_sort | Abidullah, Mohammed |
collection | PubMed |
description | Background: The aim of the study is to assess the hematological profile in oral submucous fibrosis (OSMF) patients. Methods: The study's participants (100) were divided into two groups. Group I consisted of fifty areca nut chewers with complaints of burning sensations, blanching, and stiffness of the oral mucosa. Group II consisted of fifty healthy patients as controls. A hematological profile was estimated in all subjects. Results: The control group had a mean hemoglobin (Hb) of 13.87±1.26 g/dL, while the OSMF group had a mean Hb of 11.03±2.16 g/dL (P=0.001). The mean serum iron level in the control group was 120.36±41.22 g/dL, while it was 44.97±13.45 g/dL in the OSMF group (P=0.001). The control group's mean serum vitamin B12 values were 424.77±110.95 g/dL, while the OSMF group's was 210.11±44.88 g/dL (P=0.001). In the research population, 47 patients had iron deficiency. The odds ratio (OR) was 28.11, which meant that the high prevalence of iron deficiency was predicted 28.11 times more often than in the control group. Conclusion: As part of a biochemical assessment, iron status is assessed as part of a prevention mechanism for people who are at high risk. Biochemical testing has been suggested as a potential tool for mass screening OSMF patients. |
format | Online Article Text |
id | pubmed-8900455 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-89004552022-03-08 Evaluation of Hematological Profile in Oral Submucous Fibrosis Abidullah, Mohammed Gaddikeri, Kavitha Anjum, Bushra Vairagare, Swapneel Tarani, Kulkarni Seethamsetty, Swetcha Cureus Oral Medicine Background: The aim of the study is to assess the hematological profile in oral submucous fibrosis (OSMF) patients. Methods: The study's participants (100) were divided into two groups. Group I consisted of fifty areca nut chewers with complaints of burning sensations, blanching, and stiffness of the oral mucosa. Group II consisted of fifty healthy patients as controls. A hematological profile was estimated in all subjects. Results: The control group had a mean hemoglobin (Hb) of 13.87±1.26 g/dL, while the OSMF group had a mean Hb of 11.03±2.16 g/dL (P=0.001). The mean serum iron level in the control group was 120.36±41.22 g/dL, while it was 44.97±13.45 g/dL in the OSMF group (P=0.001). The control group's mean serum vitamin B12 values were 424.77±110.95 g/dL, while the OSMF group's was 210.11±44.88 g/dL (P=0.001). In the research population, 47 patients had iron deficiency. The odds ratio (OR) was 28.11, which meant that the high prevalence of iron deficiency was predicted 28.11 times more often than in the control group. Conclusion: As part of a biochemical assessment, iron status is assessed as part of a prevention mechanism for people who are at high risk. Biochemical testing has been suggested as a potential tool for mass screening OSMF patients. Cureus 2022-02-05 /pmc/articles/PMC8900455/ /pubmed/35265435 http://dx.doi.org/10.7759/cureus.21926 Text en Copyright © 2022, Abidullah et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Oral Medicine Abidullah, Mohammed Gaddikeri, Kavitha Anjum, Bushra Vairagare, Swapneel Tarani, Kulkarni Seethamsetty, Swetcha Evaluation of Hematological Profile in Oral Submucous Fibrosis |
title | Evaluation of Hematological Profile in Oral Submucous Fibrosis |
title_full | Evaluation of Hematological Profile in Oral Submucous Fibrosis |
title_fullStr | Evaluation of Hematological Profile in Oral Submucous Fibrosis |
title_full_unstemmed | Evaluation of Hematological Profile in Oral Submucous Fibrosis |
title_short | Evaluation of Hematological Profile in Oral Submucous Fibrosis |
title_sort | evaluation of hematological profile in oral submucous fibrosis |
topic | Oral Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900455/ https://www.ncbi.nlm.nih.gov/pubmed/35265435 http://dx.doi.org/10.7759/cureus.21926 |
work_keys_str_mv | AT abidullahmohammed evaluationofhematologicalprofileinoralsubmucousfibrosis AT gaddikerikavitha evaluationofhematologicalprofileinoralsubmucousfibrosis AT anjumbushra evaluationofhematologicalprofileinoralsubmucousfibrosis AT vairagareswapneel evaluationofhematologicalprofileinoralsubmucousfibrosis AT taranikulkarni evaluationofhematologicalprofileinoralsubmucousfibrosis AT seethamsettyswetcha evaluationofhematologicalprofileinoralsubmucousfibrosis |